Pancreatic cancer, recognized as one of the deadliest cancers, poses a persistent challenge for medical professionals globally due to its aggressive behavior and resistance to conventional therapies. The dense fibrotic tissue surrounding…
A short course of immunotherapy was found to be highly effective in a subset of patients with colon cancer. The treatment, which consisted of two cycles of immunotherapy prior to surgery, was effective in almost all patients. In two-thirds…
Phenotypic plasticity is a cancer hallmark, and lung adeno-to-squamous transition (AST) triggered by LKB1 inactivation is significantly associated with drug resistance. Clinical data show that squamous transition occurs in certain lung…
(MedPage Today) -- CHICAGO -- Use of metformin didn't prevent progression of low-risk localized prostate cancer in patients on active surveillance, according to data from the randomized MAST study.
(MedPage Today) -- CHICAGO -- Germline variations did not predict the risk of taxane-induced peripheral neuropathy (TIPN) in a phase II trial involving Black women with early-stage breast cancer, but the researchers found that docetaxel…
In a recent study led by Suresh Ramalingam, MD, executive director of Winship Cancer Institute of Emory University, a new drug has shown remarkable promise in treating patients with a specific type of advanced lung cancer.
New Mexico's Memorial Medical Center says it doesn't turn away patients. Thirteen cancer patients said they met with denials of care or demands for money up-front.
CANCER survivors had a sneak preview of pioneering work at the Cancer Research UK National Biomarker Centre ahead of its official opening. The state-of-the-art facility will help experts detect cancer at an earlier stage – when there’s…
According to preliminary data from a multi-institution Phase III trial intensity modulated proton therapy (IMPT) achieved similar clinical outcomes and offered significant patient benefits when compared to traditional intensity modulated…
June is national cancer survivors month and to celebrate, a local cosmetology school is offering reduced cost services and free wig styling for those going through chemo treatment and those who’ve survived cancer.
NRG Oncology recently reported the results from the radiotherapy randomization, which was the second step of their NRG-RTOG 0848 clinical study comparing adjuvant chemotherapy with or without chemoradiation for patients with resected…
Extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy (177Lu-PSMA) beyond six cycles is an effective and well-tolerated treatment for metastatic castration-resistant prostate cancer patients, according to…